SEATTLE – The University of Washington School of Medicine is looking for volunteers for a COVID-19 booster trial.
Volunteers will participate in the second stage of a phase 1 trial which is designed to test the safety, tolerability, and immune response to a new vaccine.
Researchers hope the trial vaccine will create a immune response to multiple SARS-coV-2 proteins as well as the spike protein that is currently targeted by the Moderna, Pfizer, and Johnson & Johnson vaccines.
“With the emergence of the Delta and other COVID-19 variants, we need to stay ahead of the virus by developing effective vaccines that will aid in the prevention of all strains of COVID,” said Dr. Anna Wald, director of the UW Medicine Virology Research Clinic and head the UW School of Medicine's allergies and infectious diseases division.
To enroll in the trial, you must be 18 or older, healthy, have no significant allergies, have not gotten COVID-19 and have been vaccinated for at least four months prior to enrollment.
Participants will be asked to make nine to 14 or more in-person clinic visits and one or two telephone check-ins with staff over a 12 to 14-month period.
They will also receive one or two injections of the vaccine, have blood drawn several times to monitor results, and be asked to keep track of how they feel after each injection.
If you are interested in participating in the study, email the UW Medicine Virology Research clinic at firstname.lastname@example.org or call 206-520-4340.